Trigemina - Non-Addictive Migraine and Pain Treatment Programs - Ownership and Business Overview

Life ScienceCompany

Trigemina - Non-Addictive Migraine and Pain Treatment Programs Ownership

Who owns Trigemina - Non-Addictive Migraine and Pain Treatment Programs?

Trigemina - Non-Addictive Migraine and Pain Treatment Programs is owned by Tonix Pharmaceuticals Holding. It was acquired on June 11, 2020.

Trigemina - Non-Addictive Migraine and Pain Treatment Programs Business Overview

Where is Trigemina - Non-Addictive Migraine and Pain Treatment Programs headquartered?

Trigemina - Non-Addictive Migraine and Pain Treatment Programs is headquartered in California.

What sector is Trigemina - Non-Addictive Migraine and Pain Treatment Programs in?

Trigemina - Non-Addictive Migraine and Pain Treatment Programs is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.

Trigemina, Inc. - Non-Addictive Migraine and Pain Treatment Programs

California
United States,

Trigemina, Inc. - Non-Addictive Migraine and Pain Treatment Programs comprises TNX-1900 (formerly TI-001, oxytocin solution for intranasal delivery), is a proprietary, patented enhanced formulation of nasal oxytocin, with demonstrated activity in several non-clinical studies in pain including migraine prophylaxis and neuropsychiatric models and with safety data from non-U.S. studies.


 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.